RESUMEN
Virus infection of humans and livestock can be devastating for individuals and populations, sometimes resulting in large economic and societal impact. Prevention of virus disease by vaccination or antiviral agents is difficult to achieve. A notable exception was the eradication of human smallpox by vaccination over 30 years ago. Today, humans and animals remain susceptible to poxvirus infections, including zoonotic poxvirus transmission. Here we identified a small molecule, bisbenzimide (bisbenzimidazole), and its derivatives as potent agents against prototypic poxvirus infection in cell culture. We show that bisbenzimide derivatives, which preferentially bind the minor groove of double-stranded DNA, inhibit vaccinia virus infection by blocking viral DNA replication and abrogating postreplicative intermediate and late gene transcription. The bisbenzimide derivatives are potent against vaccinia virus and other poxviruses but ineffective against a range of other DNA and RNA viruses. The bisbenzimide derivatives are the first inhibitors of their class, which appear to directly target the viral genome without affecting cell viability.IMPORTANCE Smallpox was one of the most devastating diseases in human history until it was eradicated by a worldwide vaccination campaign. Due to discontinuation of routine vaccination more than 30 years ago, the majority of today's human population remains susceptible to infection with poxviruses. Here we present a family of bisbenzimide (bisbenzimidazole) derivatives, known as Hoechst nuclear stains, with high potency against poxvirus infection. Results from a variety of assays used to dissect the poxvirus life cycle demonstrate that bisbenzimides inhibit viral gene expression and genome replication. These findings can lead to the development of novel antiviral drugs that target viral genomes and block viral replication.
Asunto(s)
Antivirales/farmacología , Bisbenzimidazol/farmacología , Replicación del ADN/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Virus Vaccinia/efectos de los fármacos , Virus Vaccinia/fisiología , Replicación Viral/efectos de los fármacos , Animales , Línea Celular , Colorantes Fluorescentes , HumanosRESUMEN
A horse in Finland exhibited generalized granulomatous inflammation and severe proliferative dermatitis. After euthanization, we detected poxvirus DNA from a skin lesion sample. The virus sequence grouped with parapoxviruses, closely resembling a novel poxvirus detected in humans in the United States after horse contact. Our findings indicate horses may be a reservoir for zoonotic parapoxvirus.
Asunto(s)
Enfermedades de los Caballos/virología , Parapoxvirus/genética , Infecciones por Poxviridae/veterinaria , Animales , Finlandia/epidemiología , Enfermedades de los Caballos/epidemiología , Caballos , Masculino , Parapoxvirus/clasificación , Filogenia , Infecciones por Poxviridae/epidemiología , Infecciones por Poxviridae/virología , ZoonosisRESUMEN
In 2009, a novel poxvirus was identified in a North American red squirrel (Tamiasciurus hudsonicus) from Yukon, Canada. Initial molecular analyses indicated that this virus was likely to be distinct from all other known mammalian poxviruses, including those previously associated with disease in tree squirrels--squirrel fibroma virus in North America and squirrelpox virus in the UK (UK SQPV). We characterize the Canadian squirrelpox virus (Canadian SQPV) using DNA sequence analysis and negative-contrast transmission electron microscopy (TEM). Sequence analysis revealed that the Canadian SQPV is distinct from all known mammalian poxviruses but most closely related to the parapoxviruses, followed by UK SQPV. In contrast, TEM showed that the ultrastructure of Canadian SQPV is distinct from that of the parapoxviruses and UK SQPV but indistinguishable from that of other chordopoxviruses (a morphological group that includes the orthopoxviruses and leporipoxviruses). Overall, our analyses suggest a potential evolutionary relationship between UK SQPV and Canadian SQPV and supports our assertion that the Canadian virus represents a newly identified poxvirus in North American tree squirrels.
Asunto(s)
Infecciones por Poxviridae/veterinaria , Poxviridae/aislamiento & purificación , Enfermedades de los Roedores/virología , Sciuridae/virología , Animales , Animales Salvajes/virología , Canadá/epidemiología , ADN Viral/análisis , Femenino , Masculino , Microscopía Electrónica de Transmisión/veterinaria , Reacción en Cadena de la Polimerasa/veterinaria , Poxviridae/clasificación , Poxviridae/genética , Infecciones por Poxviridae/epidemiología , Infecciones por Poxviridae/patología , Infecciones por Poxviridae/virología , Enfermedades de los Roedores/epidemiología , Enfermedades de los Roedores/patología , Análisis de Secuencia de ADNRESUMEN
Ovine herpesvirus-2 (OvHV-2), a member of the gammaherpesviruses (genus Rhadinovirus), asymptomatically infects its natural host, the sheep, but causes malignant catarrhal fever (MCF) in susceptible hosts, such as cattle, deer and pigs. A permissive cell culture system for virus replication has not been identified but viral DNA is present within lymphoblastoid cell lines (LCLs) established from cases of MCF. During this study, a cDNA expression library generated from LCLs was screened with sheep sera and two cDNAs were isolated. One cDNA contained two open reading frames (ORFs) that show similarity to ORFs 58 and 59 of alcelaphine herpesvirus-1 (AlHV-1), a closely related gammaherpesvirus that also causes MCF. Both ORFs 58 and 59 are conserved throughout the gammaherpesviruses. ORF 58 is predicted to be a membrane protein, while ORF 59 has been shown to be an early lytic gene that functions as a DNA polymerase processivity factor. The second cDNA clone contained a partial ORF showing limited similarity to AlHV-1 ORF 73, a homologue of the latency-associated nuclear antigen of human herpesvirus-8, which is associated with latent infections. The full-length OvHV-2 ORF 73 was cloned subsequently by PCR. The ORFs isolated from the library were cloned into a bacterial expression vector and the recombinant proteins tested for their reactivity to sera from OvHV-2-infected animals. An ORF 59 fusion protein was recognized specifically by sera from OvHV-2-infected cattle and will be used to develop a sero-diagnostic test.